MEDXF (Medexus Pharmaceuticals) Total Assets : $145.4 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medexus Pharmaceuticals Total Assets?

Medexus Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2024 was $145.4 Mil.

Warning Sign:

If a company builds assets at 15.3% a year, faster than its revenue growth rate of 12.1% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Medexus Pharmaceuticals's average Total Assets Growth Rate was -5.50% per year. During the past 3 years, the average Total Assets Growth Rate was 7.70% per year. During the past 5 years, the average Total Assets Growth Rate was 15.30% per year. During the past 10 years, the average Total Assets Growth Rate was 78.10% per year.

During the past 13 years, Medexus Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 231.50%. The lowest was 7.30%. And the median was 36.85%.

Total Assets is connected with ROA %. Medexus Pharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2024 was 0.30%. Total Assets is also linked to Revenue through Asset Turnover. Medexus Pharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2024 was 0.18.

Medexus Pharmaceuticals Total Assets Historical Data

The historical data trend for Medexus Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Total Assets Chart

Medexus Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Assets

Get a 7-Day Free Trial

122.77

148.51

139.23

161.33

155.73

Medexus Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															166.18	160.38	155.73	147.26	145.37

Medexus Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Medexus Pharmaceuticals's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (A: Mar. 2024 )	+	Total Liabilities (A: Mar. 2024 )
	=	30.323	+	125.41
	=	155.7

Medexus Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	32.741	+	112.626
	=	145.4

Medexus Pharmaceuticals (OTCPK:MEDXF) Total Assets Explanation

Total Assets is connected with ROA %.

Medexus Pharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	0.44	/	( (147.262	+	145.367)	/ 2 )
	=	0.44	/	146.3145
	=	0.30 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Medexus Pharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	26.303	/	( (147.262	+	145.367)	/ 2 )
=	26.303	/	146.3145
=	0.18

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Medexus Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (OTCPK:MEDXF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

MDP:Canada

Address

10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.